摘要
Abstract
OBJECTIVE:To evaluate the pharmacoeconomic efficacy of clinical commonly used drugs in the treatment of lower respiratory tract bacterial infection.METHODS:120 patients with lower respiratory tract infection in No.153 Central Hospital of the Chinese People's Liberation Army were randomly assigned to receive levofloxacin for 5 days ( group A) , moxifloxacin for 7 days ( group B) or gatifloxacin for 7 days ( group C) .A cost-effectiveness analysis was performed on three groups.RESULTS: The costs in 3 groups were 287 yuan, 315 yuan and 460.6 yuan, respectively;with effective rates of 100%, 80% and 95% ( C/E) , and cost-effectiveness ratios of 2.87, 3.94 and 4.85, respectively.The incremental cost-effectiveness ratio was -1.4 for group B, as compared with -34.72 for group C.CONCLUSIONS:In the treatment of lower respiratory tract infection, Levofloxacin is effective with low cost and the least adverse reaction.关键词
呼吸道感染/经济学/药学/费用效益分析/氟喹诺酮类Key words
Respiratory tract infection/Economics/Pharmacy/Cost-effectiveness analysis/Quinolones分类
医药卫生
